Confirmatory factor analysis of 20-item toronto alexithymia scale in spanish patients with substance use disorder

Authors

  • Raul F. Palma-Álvarez Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM). Barcelona, Spain
  • Constanza Daigre Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM). Barcelona, Spain
  • Elena Ros-Cucurull Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM). Barcelona, Spain
  • Marta Perea-Ortueta Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
  • Pedro Serrano-Pérez Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
  • Germán Ortega-Hernández Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
  • Josep A. Ramos-Quiroga Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM). Barcelona, Spain
  • Lara Grau-López Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Group of Psychiatry, Mental Health and Addiction, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain; Biomedical Network Research Centre on Mental Health (CIBERSAM). Barcelona, Spain
  • Carlos Roncero Psychiatry Service, University of Salamanca Health Care Complex, Institute of Biomedicine, University of Salamanca, Salamanca, Spain; Psychiatry Unit, School of Medicine, University of Salamanca, Salamanca, Spain

Keywords:

Alexithymia, Confirmatory factor analysis, Psychometrics, Spanish, Substance use disorder, Toronto Alexithymia Scale

Abstract

Alexithymia is highly prevalent in patients with substance use disorders (SUDs) and has been implied in SUD pathogenesis and treatment outcomes. However, the psychometric properties of the most-used instrument for evaluating alexithymia (the 20-item Toronto Alexithymia Scale, TAS-20) have been scarcely studied in relation to SUD patients. Specifically, only five psychometric studies have been performed with samples of SUD patients, and no studies have focused exclusively on Spanish patients with SUDs. Therefore, the aim of the present study was to examine the internal accuracy and reliability of the TAS-20 with a sample of Spanish SUD patients (n = 126; 75.4% male; mean age 43.7 ± 14.6 years). A reliability analysis and a confirmatory factor analysis were executed, considering that TAS-20 has a three-factor structure (difficulty identifying feelings [DIF]; difficulty describing feelings [DDF]; externally oriented thinking [EOT]). The results indicated that TAS-20’s psychometric properties are acceptable for assessing alexithymia in Spanish patients with SUDs. However, the three-factor model of TAS-20 was found to fit only moderately well with the patient sample, with DIF and DDF being the most reliable and valid constructs. In contrast, the EOT factor needs further research and should be cautiously analyzed in the context of patients with addictions.

Published

2022-09-01

How to Cite

Palma-Álvarez, Raul F., et al. “Confirmatory Factor Analysis of 20-Item Toronto Alexithymia Scale in Spanish Patients With Substance Use Disorder”. Actas Españolas De Psiquiatría, vol. 50, no. 5, Sept. 2022, pp. 208-15, https://actaspsiquiatria.es/index.php/actas/article/view/1049.

Issue

Section

Original